Substance
LANADELUMAB
Global reference: every product and company linked to this substance.
- cas: 1426055-14-2
- ncit: C166535
- rxnorm: 2055641
- unii: 2372V1TKXK
DX-2930 · lanadelumab [INN] · LANADELUMAB [JAN] · LANADELUMAB [USAN] · Lanadelumab [WHO-DD] · Lanadelumab flyo [WHO-DD] · LANADELUMAB-FLYO · SHP-643 · TAKHZYRO
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- TAKHZYRO · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- TAKHZYRO · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)